Tumor necrosis factor-α and expression of the multidrug resistance- associated genes LRP and MRP

Journal of the National Cancer Institute

Volumn 89, Issue 11, 1997, Pages 807-813

  Stein, Ulrike ^a   Walther, Wolfgang ^a   Laurencot, Carolyn M ^b   Scheffer, George L ^c   Scheper, Rik J ^c   Shoemaker, Robert H ^b  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; COLON CARCINOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE;

EID: 0030952736     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.11.807     Document Type: Article

References (51)

1. Salmon SE, Soehnlen B, Dalton S, Meltzer P, Scuderi P. Effects of tumor necrosis factor on sensitive and multidrug resistant human leukemia and myeloma cell lines. Blood 1989;74: 1723-7.
2. Hofsli E, Nissen-Meyer J. Effect of erythromycin and tumor necrosis factor on the drug resistance of multidrug-resistant cells: reversal of drug resistance by erythromycin. Int J Cancer 1989;43:520-5.
3. Kikuchi A, Holan V, Minowada J. Effects of tumor necrosis factor alpha, interferon alpha and interferon gamma on non-lymphoid leukemia cell lines: growth inhibition, differentiation induction and drug sensitivity modulation. Cancer Immunol Immunother 1992;35:257-63.
4. Valenti M, Cimoli G, Parodi S, Mariani GL, Venturini M, Conte P, et al. Potentiation of tumor necrosis factor-mediated cell killing by VP16 on human ovarian cancer cell lines. In vitro results and clinical implications. Eur J Cancer 1993;29A:1157-61.
5. Borsellino N, Crescimanno M, Flandina C, Flugy A, D'Alessandro N. Combined activity of interleukin-1 alpha or TNF-alpha on multidrug resistant cell lines: evidence that TNF and DXR have synergistic antitumor and differentiation-inducing effects. Anticancer Res 1994;14:2643-8.
6. Walther W, Stein U. Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs. J Cancer Res Clin Oncol 1994; 120:471-8.
7. Walther W, Stein U, Pfeil D. Gene transfer of human TNFα into glioblastoma cells permits modulation of mdr1 expression and potentiation of chemosensitivity. Int J Cancer 1995;61: 832-9.
8. Stein U, Walther W, Shoemaker RH. Modulation of mdr1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug resistance. Br J Cancer 1996;74: 1384-91.
9. Schiller JH, Storer BE, Witt PL, Alberti D, Tombes MB, Arzoomanian R, et al. Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly. Cancer Res 1991;51:1651-8.
10. Sidhu RS, Bollon AP. Tumor necrosis factor activities and cancer therapy - a perspective. Pharmacol Ther 1993;57:79-128.
11. Stein U, Walther W, Shoemaker RH. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells. J Natl Cancer Inst 1996;88:1383-92.
12. Hasegawa S, Abe T, Naito S, Kotoh S, Kumazawa J, Hipfner DR, et al. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines. Br J Cancer 1995;71:907-13.
13. Brock I, Hipfner DR, Nielsen BS, Jensen PB, Deeley RG, Cole SP, et al. Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells. Cancer Res 1995;55;459-62.
14. Filipits M, Suchomel RW, Dekan G, Haider K, Valdimarsson G, Depisch D, et al. MRP and MDR1 gene expression in primary breast carcinomas. Clin Cancer Res 1996;2:1231-7.
15. Izquierdo MA, Shoemaker RH, Flens MJ, Scheffer GL, Wu L, Prather TR, et al. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int J Cancer 1996;65:230-7.
16. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992;258: 1650-4.
17. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SP, Deeley RG. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 1994;54:357-61.
18. Zaman GJ, Flens MJ, van Leusden MR, de Haas M, Muelder HS, Lankelma J, et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci U S A 1994;91:8822-6.
19. Abbaszadegan MR, Futscher BW, Klimecki WT, List A, Dalton WS. Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Res 1994;54:4676-9.
20. Nooter K, Westerman AM, Flens MJ, Zaman GJ, Scheper RJ, van Wingerden KE, et al. Expression of the multidrug resistance-associated protein (MRP) in human cancers. Clin Cancer Res 1995;1:1301-10.
21. Flens MJ, Zaman GJ, van der Valk P, Izquierdo MA, Schroeijers AB, Scheffer GL, et al. Tissue distribution of the multidrug resistance protein. Am J Pathol 1996;148:1237-47.
22. Scheper RJ, Broxterman HJ, Scheffer GL, Kaaijk P, Dalton WS, van Heijningen TH, et al. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 1993;53:1475-9.
23. Chugani DC, Rome LH, Kedersha NL. Evidence that vault ribonucleoprotein particles localize to the nuclear core complex. J Cell Sci 1993;106(Pt 1):23-9.
24. Scheffer GL, Wijngaard PL, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, et al. The drug resistance-related protein LRP is the human major vault protein. Nat Med 1995;1:578-82.
25. Izquierdo MA, Scheffer GL, Flens MJ, Giaccone G, Broxterman HJ, Meijer CJ, et al. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am J Pathol 1996;148:877-87.
26. Izquierdo MA, van der Zee AG, Vermorken JB, van der Valk P, Belien JA, Giaccone G, et al. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. J Natl Cancer Inst 1995;87:1230-7.
27. Schadendorf D, Makki A, Stahr C, van Dyck A, Wanner R, Scheffer GL, et al. Membrane transport proteins associated with drug resistance expressed in human melanoma. Am J Pathol 1996;147:1545-52.
28. List A, Spier CS, Grogan TM, Johnson C, Roe DJ, Greer JP, et al. Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood 1996;87:2464-9.
29. Iwahashi T, Okochi E, Ono K, Sugawara I, Tsuruo T, Mori S. Establishment of multidrug resistant colorectal carcinoma HCT-15 cell lines and their properties. Anticancer Res 1991;11:1309-12.
30. Brattain MG, Fine WD, Khaled FM, Thompson J, Brattain DE. Heterogeneity of malignant cells from a human colonie carcinoma. Cancer Res 1981;41:1751-6.
31. Wu L, Smythe AM, Stinson SF, Mullendore LA, Monks A, Scudiero DA, et al. Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening. Cancer Res 1992;52:3029-34.
32. Chu G, Hayakawa H, Berg P. Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res 1987;15: 1311-26.
33. Walther W, Stein U, Eder C. RNA analysis using miniprep RNA in reverse transcription PCR. Biotechniques 1994;17:674-5.
34. Brenner CA, Daniel SL, Adler RR. Cytokine mapping: observation and quantification of cytokine in small numbers of cells using polymerase chain reaction. In: Balkwill FR, editor. Cytokines - a practical approach. Oxford: Oxford Univ Press, 1991:51-9.
35. Flens MJ, Izquierdo MA, Scheffer GL, Fritz JM, Meijer CJ, Scheper RJ, et al. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res 1994;54:4557-63.
36. Stephens JM, Pekala PH. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J Biol Chem 1991;266:21839-45.
37. Whitsett JA, Clark JC, Wispe JR, Pryhuber GS. Effects of TNF-alpha and phorbol ester on human surfactant protein and MnSOD gene transcription in vitro. Am J Physiol 1992;262: L688-93.
38. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor KB. Proc Natl Acad Sci U S A 1989;86:2336-40.
39. Brach MA, Gruss HJ, Sott C, Herrmann F. The mitogenic response to tumor necrosis factor alpha requires c-Jun/AP-1. Mol Cell Biol 1993; 13:4284-90.
40. Raj GV, Khalili K. Identification and characterization of a novel GGA/C-binding protein, GBP-i, that is rapidly inducible by cytokines. Mol Cell Biol 1994;14:7770-81.
41. Ueda K, Pastan I, Gottesman MM. Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene. J Biol Chem 1987;262:17432-6.
42. Ogura M, Takatori T, Tsuruo T. Purification and characterization of NF-R1 that regulates the expression of the human multidrug resistance (MDR1) gene. Nucleic Acids Res 1992; 20:5811-7.
43. Goldsmith ME, Madden MJ, Morrow CS, Cowan KH. A Y-box consensus sequence is required for basal expression of the human multidrug resistance (mdr1) gene. J Biol Chem 1993;268:5856-60.
44. Uchiumi T, Kohno K, Tanimura H, Hidaka K, Asakuno K, Abe K, et al. Involvement of protein kinase in environmental stress-induced activation of human multidrug resistance 1 (MDR1) gene promoter. FEBS Lett 1993;326: 11-6.
45. Combates NJ, Rzepka RW, Chen YN, Cohen D. NF-IL6, a member of the C/EBP family of transcription factors, binds and trans-activates the human MDR1 gene promoter. J Biol Chem 1994;269:29715-9.
46. Zhu Q, Center MS. Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to Adriamycin. Cancer Res 1994;54:4488-92.
47. Zhu Q, Center MS. Evidence that SP1 modulates transcriptional activity of the multidrug resistance-associated protein gene. DNA Cell Biol 1996;15:105-11.
48. Scheper R, Scheffer GL, Flens MJ, Van der Valk P, Meijer CJ, Pinedo HM, et al. Role of the LRP/major vault protein in multidrug resistance. In: Gupta S, Tsuruo T, editors. Multidrug resistance in cancer cells: cellular, biochemical, molecular and biological aspects. New York: John Wiley and Sons, 1996:109-18.
49. Bech-Hansen NT, Till JE, Ling V. Pleiotropic phenotype of cholchicine-resistant CHO cells: cross-resistance and collateral sensitivity. J Cell Physiol 1976;88:23-31.
50. Aldrich CD. Pleiotropic phenotype of cultured murine cells resistant to maytansine, vincristine, colchicine, and adriamycin. J Natl Cancer Inst 1979;63:751-7.
51. Shoemaker R, Wolpert-DeFilippes M, Plowman J, Abbott B, Venditti J, Trader M, et al. Pleiotropic resistance and drug development. Prog Clin Biol Res 1986;223:143-9.